52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

PHASE3CompletedINTERVENTIONAL
Enrollment

891

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2010

Conditions
Type 2 Diabetes
Interventions
DRUG

Metformin

open-label metformin

DRUG

Sulphonylurea

Glipizide 5-20 mg capsules (titrated to optimal effect or highest tolerable dose during 18 weeks)

DRUG

Saxagliptin

Saxagliptin 5 mg tablets

Trial Locations (94)

Unknown

Research Site, Hanko

Research Site, Helsinki

Research Site, Kuopio

Research Site, Kuusankoski

Research Site, Mikkeli

Research Site, Oulu

Research Site, Tampere

Research Site, Aschaffenburg

Research Site, Berlin

Research Site, Dortmund

Research Site, Frankfurt

Research Site, Hamburg

Research Site, Hanover

Research Site, Mainz

Research Site, Mannheim

Research Site, Mülheim

Research Site, Pirna

Research Site, Ratzeburg

Research Site, Reinfeld

Research Site, Rhaunen

Research Site, Schmiedeberg

Research Site, Tübingen

Research Site, Wahlstedt

Research Site, Weinheim

Research Site, Balatonfüred

Research Site, Békéscsaba

Research Site, Budapest

Research Site, Debrecen

Research Site, Gyula

Research Site, Kalocsa

Research Site, Kaposvár

Research Site, Kecskemét

Research Site, Miskolc

Research Site, Mosonmagyaróvár

Research Site, Nyíregyháza

Research Site, Székesfehérvár

Research Site, Bangalore

Research Site, Indore

Research Site, Mumbai

Research Site, Jaipur

Research Site, 's-Hertogenbosch

Research Site, Beek en Donk

Research Site, Deurne

Research Site, Dordrecht

Research Site, Losser

Research Site, Nijverdal

Research Site, Rijswijk

Research Site, Roelofarendsveen

Research Site, Rotterdam

Research Site, The Hague

Research Site, Volendam

Research Site, Bergen

Research Site, Elverum

Research Site, Flatåsen

Research Site, Hamar

Research Site, Hønefoss

Research Site, Inderoy

Research Site, Oslo

Research Site, Rådal

Research Site, Skedsmokorset

Research Site, Sogndal

Research Site, Spikkestad

Research Site, Trollåsen

Research Site, Kazan'

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Saint Petersburg

Research Site, Yaroslavl

Research Site, Dolný Kubín

Research Site, Kosice - Tahanovce

Research Site, Moldava nad Bodvou

Research Site, Ružomberok

Research Site, Trnava

Research Site, Žilina

Research Site, Wŏnju

Research Site, Guri-si

Research Site, Seongnam-si

Research Site, Incheon

Research Site, Seoul

Research Site, Uijeongbu-si

Research Site, Annan

Research Site, Whitstable

Research Site, Hamilton

Research Site, Salford

Research Site, Crawley

Research Site, Bradford-on-Avon

Research Site, Blackpool

Research Site, Coatbridge

Research Site, Coventry

Research Site, Glasgow

Research Site, Motherwell

Research Site, Newcastle

Research Site, Sheffield

Research Site, Ho Chi Minh City

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY